Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001562180-22-005979 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-09 | 2022-08-05 | SNDX | Legault Pierre | Dir | M - OptEx | $9.22 | +24.0K | 46.0K | +109% | +$221.3K |
| DM | 2022-08-09 | 2022-08-05 | SNDX | Legault Pierre | Dir | S - Sale+OE | $23.02 | -24.0K | 32.0K | -43% | -$552.5K |
| DM | 2022-08-09 | 2022-08-05 | SNDX | Legault Pierre | Dir | M - OptEx | $0.00 | -24.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | M | A | 10,000 | $9.63 | 42,000 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-05 | S | D | 10,000 | $23.02 | 32,000 | D | — | — | (F2) The sale prices ranged from $23.00 to $23.12 |
| 3 | Common | Common Stock | 2022-08-05 | M | A | 14,000 | $8.93 | 46,000 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-05 | S | D | 14,000 | $23.02 | 32,000 | D | — | — | (F2) The sale prices ranged from $23.00 to $23.12 |
| 5 | Derivative | Stock Options (Right to buy) | 2022-08-05 | M | D | 10,000 | $0.00 | 0 | D | $9.63 · — to 2028-02-08 | 10,000 Common Stock | (F3) This option is fully vested. |
| 6 | Derivative | Stock Options (Right to buy) | 2022-08-05 | M | D | 14,000 | $0.00 | 0 | D | $8.93 · — to 2028-05-23 | 14,000 Common Stock | (F3) This option is fully vested. |